Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to CANF Stock Lookup

Can-Fite BioPharma (CANF) – Analyst EPS Change

Mar 30, 2015 12:22 PM UPDATE: Can-Fite BioPharma's (CANF) CF101 Phase 2/3 Missed Primary Endpoint; Roth Downgrades to Neutral

Back to CANF Stock Lookup